Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer
University of Colorado Cancer Center · University of Colorado Denver · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
675
total citations
- FWCI
- 36.29
- Percentile
- 100%
- References
- 65
Citations per year
Authors
11- AWAndrew WeickhardtCorresponding
University of Colorado Cancer Center, University of Colorado Denver
- BSBenjamin Scheier
University of Colorado Denver, University of Colorado Cancer Center
- JBJoseph Burke
University of Colorado Cancer Center, University of Colorado Denver
- GNGregory N. Gan
University of Colorado Cancer Center, University of Colorado Denver
- XLXian Lu
Colorado School of Public Health
Topics & keywords
Topics
Keywords
- Crizotinib
- Medicine
- Erlotinib
- Lung cancer
- Oncology
- Gefitinib
- Tyrosine kinase
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.